Skip to content
Humira

Humira

Adalimumab

Adalimumab injectable solution for rheumatoid arthritis and psoriatic arthritis. A biologic that blocks TNF-alpha, a molecule that fuels joint inflammation.

Active ingredient
Adalimumab
Route
Subcutaneous use
Form
Injectable Solution
Strengths
20mg / 0.4ml · 40mg / 0.8ml

This listing uses Humira as a reference name. A generic equivalent is supplied; its exact brand and manufacturer are confirmed before supply.

Prescription and consultation requirements for Humira vary by destination and are determined by the fulfilment partner.

Humira details

Alternative names
adalimumab
Therapeutic class
Tumour Necrosis Factor (TNF) Blocker
Pharmacological class
Monoclonal Antibody
Contraindications
severe active infection; moderate to severe congestive heart failure
Minor side effects
injection site pain; headache; rash
Moderate side effects
upper respiratory tract infection; sinusitis; nausea
Dosage forms
Injectable Solution
Administration route
Subcutaneous use
Supply category
Prescription-only medicine (POM)
Originator
AbbVie
Onset Time
2–4 weeks
Duration
10–14 days
Storage instructions
Store between 2°C and 8°C. Do not freeze.
Drug interactions
Abatacept; Anakinra; Live Vaccines
Age restrictions
Approved for children over two years and adults based on indication.
Serious side effects

severe systemic sepsis, requires immediate medical attention; malignancy development, requires immediate medical attention; demyelinating disease activation, requires immediate medical attention

Patient summary

Adalimumab injectable solution for rheumatoid arthritis and psoriatic arthritis. A biologic that blocks TNF-alpha, a molecule that fuels joint inflammation.

Mechanism of action

Binds specifically to TNF-alpha, neutralising its interaction with cell surface receptors to halt the inflammatory cascade.

Pregnancy and breastfeeding

Pregnancy: Consult clinician. Breastfeeding: Confirm breastfeeding suitability with a qualified clinician or pharmacist before use.

What you will receive

Humira is used here as a reference originator brand name to identify the medicine. We are not affiliated with the brand owner, and this listing does not offer the originator product.

  • The supplied product is a generic equivalent containing Adalimumab, not the originator brand shown as the reference.
  • The exact generic brand, manufacturer and dispatch location are confirmed based on the product, destination and available manufacturer or partner warehouse.
  • Check the final product details at checkout before confirming an order.

How we compare medicine brands and generics